A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

September 4, 2024

Study Completion Date

October 3, 2024

Conditions
Huntington's Disease
Interventions
DRUG

SAGE-718

Oral capsules.

DRUG

Placebo

SAGE-718-matching oral capsules.

Trial Locations (49)

2145

Sage Investigational Site, Westmead

3162

Sage Investigational Site, Bethlehem

4029

Sage Investigational Site, Herston

6009

Sage Investigational Site, Nedlands

10032

Sage Investigational Site, New York

14221

Sage Investigational Site, Buffalo

19107

Sage Investigational Site, Philadelphia

20007

Sage Investigational Site, Washington D.C.

21287

Sage Investigational Site, Baltimore

23298

Sage Investigational Site, Richmond

27599

Sage Investigational Site, Chapel Hill

27705

Sage Investigational Site, Durham

29425

Sage Investigational Site, Charleston

33431

Sage Investigational Site, Boca Raton

33486

Sage Investigational Site, Boca Raton

33612

Sage Investigational Site, Tampa

37212

Sage Investigational Site, Nashville

38157

Sage Investigational Site, Memphis

43614

Sage Investigational Site, Toledo

45219

Sage Investigational Site, Cincinnati

46202

Sage Investigational Site, Indianapolis

48334

Sage Investigational Site, Farmington Hills

52242

Sage Investigational Site, Iowa City

53792

Sage Investigational Site, Madison

60611

Sage Investigational Site, Chicago

60612

Sage Investigational Site, Chicago

66160

Sage Investigational Site, Kansas City

72205

Sage Investigational Site, Little Rock

77030

Sage Investigational Site, Houston

80113

Sage Investigational Site, Englewood

90095

Sage Investigational Site, Los Angeles

92037

Sage Investigational Site, La Jolla

95817

Sage Investigational Site, Sacramento

96817

Sage Investigational Site, Honolulu

98034

Sage Investigational Site, Kirkland

99202

Sage Investigational Site, Spokane

02129

Sage Investigational Site, Boston

02215

Sage Investigational Site, Boston

B3S 1N2

Sage Investigational Site, Halifax

M2K 1E1

Sage Investigational Site, North York

H2X 0A9

Sage Investigational Site, Montreal

SW17 0QT

Sage Investigational Site, Tooting

AB25 2ZA

Sage Investigational Site, Aberdeen

B15 2FG

Sage Investigational Site, Birmingham

CF10 3AX

Sage Investigational Site, Cardiff

LS7 4SA

Sage Investigational Site, Leeds

NE6 4QD

Sage Investigational Site, Newcastle upon Tyne

PL6 8BT

Sage Investigational Site, Plymouth

SO16 6YD

Sage Investigational Site, Southampton

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY